Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System
Status:
Terminated
Trial end date:
2003-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Current therapies for childhood Rhabdoid tumors provide limited benefit to the
patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove
beneficial in the treatment of childhood Rhabdoid tumors.
PURPOSE: This study is being performed to determine the effects (good and bad) that
Antineoplaston therapy has on children (> 6 months of age) with Rhabdoid tumors.